data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgODUuMzMzIDUxMiAzNDEuMzMzIj48cGF0aCBmaWxsPSIjRkZEQTQ0IiBkPSJNMCA4NS4zMzFoNTEydjM0MS4zMzdIMHoiLz48cGF0aCBkPSJNMCA4NS4zMzFoNTEydjExMy43NzVIMHptMCAyMjcuNTUxaDUxMnYxMTMuNzc1SDB6IiBmaWxsPSIjRDgwMDI3Ii8+PC9zdmc+Español
data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgODUuMzMzIDUxMiAzNDEuMzMzIj48cGF0aCBmaWxsPSIjRkZGIiBkPSJNMzQxLjMzNCA4NS4zM0gwdjM0MS4zMzJoNTEyVjg1LjMzeiIvPjxwYXRoIGZpbGw9IiM2REE1NDQiIGQ9Ik0wIDg1LjMzM2gxNzAuNjYzVjQyNi42N0gweiIvPjxwYXRoIGZpbGw9IiNEODAwMjciIGQ9Ik0zNDEuMzM3IDg1LjMzM0g1MTJWNDI2LjY3SDM0MS4zMzd6Ii8+PC9zdmc+Italiano
data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgODUuMzMzIDUxMiAzNDEuMzMzIj48cGF0aCBmaWxsPSIjRkZGIiBkPSJNMCA4NS4zMzFoNTEydjM0MS4zMzdIMHoiLz48cGF0aCBmaWxsPSIjMDA1MkI0IiBkPSJNMCA4NS4zMzFoMTcwLjY2M3YzNDEuMzM3SDB6Ii8+PHBhdGggZmlsbD0iI0Q4MDAyNyIgZD0iTTM0MS4zMzcgODUuMzMxSDUxMnYzNDEuMzM3SDM0MS4zMzd6Ii8+PC9zdmc+Français
QQQ
––%
DIA
––%
SPY
––%
TLT
––%
GLD
––%
BTC/USD
––%
Contribute
data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgODUuMzMzIDUxMiAzNDEuMzMzIj48cGF0aCBmaWxsPSIjRkZEQTQ0IiBkPSJNMCA4NS4zMzFoNTEydjM0MS4zMzdIMHoiLz48cGF0aCBkPSJNMCA4NS4zMzFoNTEydjExMy43NzVIMHptMCAyMjcuNTUxaDUxMnYxMTMuNzc1SDB6IiBmaWxsPSIjRDgwMDI3Ii8+PC9zdmc+Español
data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgODUuMzMzIDUxMiAzNDEuMzMzIj48cGF0aCBmaWxsPSIjRkZGIiBkPSJNMzQxLjMzNCA4NS4zM0gwdjM0MS4zMzJoNTEyVjg1LjMzeiIvPjxwYXRoIGZpbGw9IiM2REE1NDQiIGQ9Ik0wIDg1LjMzM2gxNzAuNjYzVjQyNi42N0gweiIvPjxwYXRoIGZpbGw9IiNEODAwMjciIGQ9Ik0zNDEuMzM3IDg1LjMzM0g1MTJWNDI2LjY3SDM0MS4zMzd6Ii8+PC9zdmc+Italiano
data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgODUuMzMzIDUxMiAzNDEuMzMzIj48cGF0aCBmaWxsPSIjRkZGIiBkPSJNMCA4NS4zMzFoNTEydjM0MS4zMzdIMHoiLz48cGF0aCBmaWxsPSIjMDA1MkI0IiBkPSJNMCA4NS4zMzFoMTcwLjY2M3YzNDEuMzM3SDB6Ii8+PHBhdGggZmlsbD0iI0Q4MDAyNyIgZD0iTTM0MS4zMzcgODUuMzMxSDUxMnYzNDEuMzM3SDM0MS4zMzd6Ii8+PC9zdmc+Français
Personal Finance
Alts
Best Real Estate Crowdfunding Platforms
REITs Versus Crowdfunding
How to Invest in Artwork
Best Alternative Investments
Best Alternative Investment Platforms
Crypto
Cannabis
News
Earnings
Interviews
Deals
Regulations
Psychedelics
TV
YouTube
Video
Podcasts
Trading School
My Stocks
Tools
Premium
QQQ
––%
DIA
––%
SPY
––%
TLT
––%
GLD
––%
BTC/USD
––%
Annexon
(NASDAQ:ANNX)
$3.78
0.01[0.27%]
Last update: 9:46AM
15 minutes delayed
Day High/Low3.68 - 3.84
52 Week High/Low2.06 - 23.84
Open / Close3.78 / -
Float / Outstanding36.4M / 38.6M
Vol / Avg.3.6K / 646.7K
Mkt Cap145.8M
P/E-
50d Avg. Price3.18
Div / Yield-
Payout Ratio-
EPS-0.92
Total Float36.4M

Annexon (NASDAQ:ANNX), Quotes and News Summary

Annexon (NASDAQ: ANNX)

Day High/Low3.68 - 3.84
52 Week High/Low2.06 - 23.84
Open / Close3.78 / -
Float / Outstanding36.4M / 38.6M
Vol / Avg.3.6K / 646.7K
Mkt Cap145.8M
P/E-
50d Avg. Price3.18
Div / Yield-
Payout Ratio-
EPS-0.92
Total Float36.4M
Benzinga - Jun 8, 2022, 4:08AM
Benzinga - Jun 7, 2022, 12:19PM
Benzinga - Jun 7, 2022, 6:37AM
Benzinga - May 10, 2022, 8:10AM
Benzinga - May 9, 2022, 4:18PM
Benzinga - Apr 19, 2022, 12:07PM
Benzinga - Apr 19, 2022, 4:51AM
Benzinga - Apr 8, 2022, 6:47AM
Benzinga - Apr 7, 2022, 6:32AM
Benzinga - Mar 3, 2022, 4:02PM
Benzinga - Mar 1, 2022, 4:13PM
load more
Sector: Health Care.Industry: Biotechnology
Annexon Inc is a clinical-stage biopharmaceutical company developing a pipeline of novel therapies for patients with classical complement-mediated disorders of the body, brain, and eye. Its pipeline is based on its platform technology addressing well-researched classical complement-mediated autoimmune and neurodegenerative disease processes, both of which are triggered by aberrant activation of C1q. Its pipeline of product candidates is designed to block the activity of C1q and the entire classical complement pathway in a broad set of complement-mediated diseases. Annexon's product candidates are ANX005, for autoimmune & neurodegenerative disorders; ANX007, for neurodegenerative ophthalmic disorders; and ANX009, for systemic autoimmune diseases.
Read More

Earnings

see more
Q2 2022Est.ActualSurprise
EPS
(EXPECTED)2022-08-15
REV
Q1 2022Est.ActualSurprise
EPS-0.920
REV0

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target

Annexon Questions & Answers

Q
How do I buy Annexon (ANNX) stock?
A

You can purchase shares of Annexon (NASDAQ: ANNX) through any online brokerage.

View our list of the best stock brokerages.

Q
Who are Annexon's (ANNX) competitors?
Q
What is the target price for Annexon (ANNX) stock?
A

The latest price target for Annexon (NASDAQ: ANNX) was reported by HC Wainwright & Co. on Tuesday, May 10, 2022. The analyst firm set a price target for 30.00 expecting ANNX to rise to within 12 months (a possible 693.65% upside). 4 analyst firms have reported ratings in the last year.

Q
Current Stock Price for Annexon (ANNX)?
A

The stock price for Annexon (NASDAQ: ANNX) is $3.78 last updated Today at July 1, 2022, 1:46 PM UTC.

Q
Does Annexon (ANNX) pay a dividend?
A

There are no upcoming dividends for Annexon.

Q
When is Annexon (NASDAQ:ANNX) reporting earnings?
A

Annexon’s Q2 earnings are confirmed for Monday, August 15, 2022.

Q
Is Annexon (ANNX) going to split?
A

There is no upcoming split for Annexon.

Q
What sector and industry does Annexon (ANNX) operate in?
A

Annexon is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.